These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9922787)

  • 1. [Radiation sensitizing agents for hypoxic cells: past, present and future].
    Lartigau E
    Cancer Radiother; 1998 Dec; 2(6):775-80. PubMed ID: 9922787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
    Chaplin DJ; Horsman MR; Aoki DS
    Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.
    Horsman MR
    Acta Oncol; 1995; 34(5):571-87. PubMed ID: 7546822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
    Stüben G; Stuschke M; Knühmann K; Horsman MR; Sack H
    Radiother Oncol; 1998 Aug; 48(2):143-8. PubMed ID: 9783885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitising agents for the radiotherapy of cancer: advances in traditional and hypoxia targeted radiosensitisers.
    Bischoff P; Altmeyer A; Dumont F
    Expert Opin Ther Pat; 2009 May; 19(5):643-62. PubMed ID: 19441939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between radiosensitivity, percentage hypoxic cells and pO2 measurements in one rodent and two human tumor xenografts.
    Thomas CD; Chavaudra N; Martin L; Guichard M
    Radiat Res; 1994 Jul; 139(1):1-8. PubMed ID: 8016297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of tumour size on radiosensitization by misonidazole.
    Stanley JA; Peckham MJ; Steel GG
    Br J Cancer Suppl; 1978 Jun; 3():220-4. PubMed ID: 277232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic cell sensitization: low-dose intrinsic radiosensitivity is predictive for etanidazole efficacy in a panel of human tumour cell lines.
    Wouters BG; Sy AM; Skarsgard LD
    Int J Radiat Biol; 1996 Dec; 70(6):719-33. PubMed ID: 8980670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental studies on the possible influence of invasive oxygen measurements on tumour radiosensitivity.
    Stüben G; Stuschke M; Knühmann K; Pöttgen C; Sack H
    Acta Oncol; 1998; 37(4):369-73. PubMed ID: 9743459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiation.
    Brown JM; Lemmon MJ
    Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):457-61. PubMed ID: 1995531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation response of the cells of a human malignant melanoma xenograft. Effect of hypoxic cell radiosensitizers.
    Rofstad EK
    Radiat Res; 1981 Sep; 87(3):670-83. PubMed ID: 7280191
    [No Abstract]   [Full Text] [Related]  

  • 12. The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo.
    Horsman MR; Wood PJ; Chaplin DJ; Brown JM; Overgaard J
    Radiother Oncol; 1990 May; 18(1):49-57. PubMed ID: 2141694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay.
    McLaren DB; Pickles T; Thomson T; Olive PL
    Radiother Oncol; 1997 Nov; 45(2):175-82. PubMed ID: 9424009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys.
    Rojas A; Joiner MC; Hodgkiss RJ; Carl U; Kjellen E; Wilson GD
    Int J Radiat Oncol Biol Phys; 1992; 23(2):361-6. PubMed ID: 1587757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic cell sensitisers in radiotherapy.
    Adams GE; Dische S; Fowler JF; Thomlinson RH
    Lancet; 1976 Jan; 1(7952):186-8. PubMed ID: 54693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice.
    Stüben G; Thews O; Pöttgen C; Knühmann K; Vaupel P; Stuschke M
    J Cancer Res Clin Oncol; 2001; 127(6):346-50. PubMed ID: 11414194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lung colony clonogenic cell assay for human malignant melanoma in immune-suppressed mice and its use to determine chemosensitivity, radiosensitivity and the relationship between tumour size and response to therapy.
    Thomas JM
    Br J Surg; 1979 Oct; 66(10):696-700. PubMed ID: 509043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SR 4233: a tumor specific radiosensitizer active in fractionated radiation regimes.
    Brown JM; Lemmon MJ
    Radiother Oncol; 1991; 20 Suppl 1():151-6. PubMed ID: 2020764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiosensitizers of hypoxic cells].
    Girinsky T; Cosset JM; Malaise EP; Guichard M
    Rev Prat; 1989 Nov; 39(27):2440. PubMed ID: 2602869
    [No Abstract]   [Full Text] [Related]  

  • 20. Broad-shouldered survival curves of a human melanoma xenograft. Implications for radiation therapy in the absence and presence of misonidazole.
    Rofstad EK; Brustad T
    Acta Radiol Oncol; 1981; 20(4):261-5. PubMed ID: 6277155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.